Legacy App users can now access the Health Portal – just reset your password using email as username.

HCG or Clomid for Fertility on TRT? (TRT Q&As)

HCG or Clomid for Fertility on TRT? (TRT Q&As)

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Timeline

Timestamp
Topic
00:05
Should I use Clomid or HCG to improve fertility and testicle size while on TRT?

Dr. O’Connor discusses how long-term testosterone can suppress the reproductive axis and explains why HCG may be used differently depending on age, duration of TRT, prior steroid exposure, and the degree of testicular suppression. He also discusses his approach when fertility becomes the primary goal.
05:00
After stopping a Dianabol and Trenbolone cycle, can I start TRT, and can coming off too quickly throw my hormones out of balance?

Dr. O’Connor explains that withdrawal after potent anabolic steroid use can be difficult and discusses PCT, gradual transition, and why recovery varies considerably between men. He also notes that some men may consider TRT rather than experiencing a severe hormonal crash, particularly after substantial prior androgen exposure.
08:10
How long is a multidose vial of testosterone safe to keep using after it has been opened?

Dr. O’Connor discusses potency versus sterility, noting that testosterone may remain potent for a long time but that contamination is a separate concern. He describes roughly 90 days as a more conservative practical timeframe rather than assuming an opened vial remains safe indefinitely.
10:20
Could restarting TRT and Anavar treat my very low heart rate after stopping testosterone?

A 38-year-old man reports a severe reaction after stopping testosterone and Anavar, including loss of muscle, insomnia, chest pain, and a resting heart rate around 30 beats per minute. Dr. O’Connor says testosterone and Anavar should not be viewed as treatment for profound bradycardia and emphasizes further cardiac evaluation, potentially including an electrophysiologist.
13:50
What should I do after going through major personal and health problems while trying to get myself back on track?

Dr. O’Connor responds to a member who describes significant personal difficulties and says he appears to be doing better. He encourages continued participation in the meetings so they can keep reviewing his situation and providing educational information as he moves forward.
15:00
Should I stop Ostarine and Cardarine after my AST and ALT became extremely elevated in only 10 days?

The member reports AST and ALT rising dramatically after starting Ostarine and Cardarine. Dr. O’Connor considers the elevations concerning, discusses stopping the agents and repeating laboratory testing, and emphasizes medical evaluation to make sure there is not another liver problem contributing to the abnormal results.

Video Summary

This mailbag discussion focuses on questions that arise once testosterone therapy has been established for an extended period. It explains how long-term stability differs from early-phase changes and why dramatic shifts become less common over time. Ongoing treatment is framed as maintenance rather than continuous optimization.

A central portion examines how expectations should evolve as therapy matures. The episode discusses why consistent symptom control, rather than progressive gains, is often the appropriate goal. Long-term variability is contextualized to avoid unnecessary concern.
The closing segment reinforces testosterone therapy as sustained clinical care. Routine monitoring, proportional responses, and realistic expectations are emphasized. Hormone therapy is positioned as supporting long-term stability rather than ongoing escalation.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an androgen hormone used therapeutically to treat confirmed testosterone deficiency and related symptoms. In this mailbag episode, testosterone therapy is discussed in relation to long-term treatment expectations.

Condition Callouts

Condition
Description
Testosterone deficiency
Testosterone deficiency is a clinical condition characterized by low circulating testosterone levels with associated symptoms. It is referenced as the indication for therapy while emphasizing long-term management.

Key Takeaways

  • Long-term testosterone therapy emphasizes stability rather than continual change.
  • Expectations should evolve after initial adjustment.
  • Some variability remains normal over time.
  • Maintenance goals reduce unnecessary concern.
  • Routine follow-up supports sustained benefit.